Journals / Turkish Thoracic Journal / 2015 / Cilt: 16 - Sayı: 2

Comparison of patients with community-acquired pneumonia who did and did not receive treatment in accordance with the 2009 pneumonia guideline of Turkish thoracic society

Pages
64–67
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: Hospital stay length, treatment cost, and treatment effcacy were similar in patients who were and were not administered treatment in accordance with the guideline.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: The purpose of our study was to compare community-acquired pneumonia (CAP) patients who were and were not ad - ministered treatment in accordance with the Turkish Thoracic Society (TTS) 2009 pneumonia guideline in terms of hospital stay length, treatment cost, and treatment effcacy.
📊
Key Findings & Data:Taking into consideration the Turkish Thoracic Society Consensus Report on the Diagnosis and Treatment of Community-acquired pneumonia in Adults (2009), the patients recorded in the database were evaluated in terms of conformity to the guideline.
💡
Conclusion & Impact:CONCLUSION: Hospital stay length, treatment cost, and treatment effcacy were similar in patients who were and were not administered treatment in accordance with the guideline.
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Özet

OBJECTIVES: The purpose of our study was to compare community-acquired pneumonia (CAP) patients who were and were not ad - ministered treatment in accordance with the Turkish Thoracic Society (TTS) 2009 pneumonia guideline in terms of hospital stay length, treatment cost, and treatment effcacy. MATERIAL AND METHODS: Patients who were admitted to our hospital and who were diagnosed with CAP were included in the study. Demo- graphic characteristics of the patients, symptoms at the time of diagnosis, physical examination, laboratory and radiological fndings, treatments, response to treatment at follow-up, length of hospital stay, and direct cost of treatment were recorded in the TTS pneumonia database (TURCAP: TUR- KEY Community Acquired Pneumonia). Taking into consideration the Turkish Thoracic Society Consensus Report on the Diagnosis and Treatment of Community-acquired pneumonia in Adults (2009), the patients recorded in the database were evaluated in terms of conformity to the guideline. RESULTS: This present study included 156 patients diagnosed with CAP. Sixty-six patients (42.3%) were females, and 96 (57.7%) were males, and the mean age of the patients was 70.4 years. The most common symptoms on admission were cough (94.9%), expectoration of purulent sputum (77.6%), and fever (58%). Comorbid diseases were chronic obstructive pulmonary disease (COPD; 29.5%), asthma (3.2%), lung cancer (8.3%), cardiovascular diseases (32.7%), and diabetes mellitus (12.8%). It was observed that 67.3% of the patients received treatment in accordance with the guideline. No signifcant difference was found in terms of gender and symptoms between the groups that received and did not receive treatment in accordance with the guideline. The mean age of the patients who received treat- ment according to the guideline was higher than that of the patients who did not receive treatment according to the guideline; COPD was more frequent in the group of patients who received treatment according to the guideline. Pneumonia Severity Index and Confusion, Urea, Respiratory rate, Blood pressure-Age>65 scores of the patients who were treated according to the guideline was higher and treat- ment resulted in death in 8% of these patients. CONCLUSION: Hospital stay length, treatment cost, and treatment effcacy were similar in patients who were and were not administered treatment in accordance with the guideline.

🔖

Cite This Article

KILIÇ, Ö. S., KILINÇ, O., ELLİDOKUZ, H. (2015). Comparison of patients with community-acquired pneumonia who did and did not receive treatment in accordance with the 2009 pneumonia guideline of Turkish thoracic society. Turkish Thoracic Journal, Cilt: 16 - Sayı: 2, 64–67. https://ajindex.com/articles/418154

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. T.C. Sağlık Bakanlığı, Refik Saydam Hıfzıssıhha Merkezi Başkanlığı Hıfzıssıhha Mektebi Müdürlüğü, Başkent Üniversi- tesi Ulusal Hastalık Yükü Ve Maliyeti Etkinlik Projesi, 2004
  2. Türk Toraks Derneği Erişkinlerde Toplumda Gelişen Pnömoni Tanı Ve Tedavi Uzlaşı Raporu; Türk Toraks Dergisi 2009;10:1- 32
  3. Türkiye İstatistik Kurumu, Sağlık İstatistikleri, 2004 (http://www. tuik.gov.tr)
  4. Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. Antibiotic therapy and 48-hour mortality for patients with pneumonia. Am J Med 2006;119:859-64. [CrossRef] 5. Al-Abri S, Al-Maashanib S, Ziad A. Memishc, Nick J. Beech- ingd; An audit of inpatient management of community-acquired pneumonia in Oman:A comparison with regional clinical guidelines. J Infect Public Health 2012;5:250-6. [CrossRef] 6. Gökırmak M, Hasanoğlu HC, Yıldırım Z, ve ark. Türk Toraks Derneği Pnömoni Rehberi’ne uygun tedavi verilen ve verilmey- en toplum kökenli pnömonilerde başarı oranları. Tuberk Toraks 2001;49:297-311
  5. Doruk S, Tertemiz KC, Kömüs N, ve ark. Toplum kökenli pnö - moni ve hastane maliyeti. Tuberk Toraks 2009;57:48-55
  6. Sevinç B, Akbaba B, Afşar Bilgen B. Toplumda gelişen pnömo - nili hastalara klinik yaklaşım. İzmir Göğüs Hastanesi Dergisi 2009;23:107-16
  7. Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community- acquired pneumonia. Am J Med 2005;118:384-92. [CrossRef] 10. Brown PD. Adherence to guidelines for community-acquired pneumonia:dose it decrease cost of care? Pharmacoeconomics 2004;22:413-20. [CrossRef] 11. BTS Guidelines fort he management of community-acquired pneumonia in adults. Thorax 2001;56(Suppl 4):1-64. [CrossRef]